Effect of primary cilium-associated genes expression on the survival of mesothelioma patients: In silico investigation of TCGA data.

E. Rouka (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece)

Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Session: Novel directions in pleural disease: bench to bedside
Session type: E-poster session
Number: 1135
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Rouka (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece). Effect of primary cilium-associated genes expression on the survival of mesothelioma patients: In silico investigation of TCGA data.. 1135

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Integrated analysis of COPD gene expression data reveals specific pathway signatures
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010


Identification of reference genes in lung cancer from RNA-seq data
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017


Comparative gene expression analysis in lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018


Molecular profiling of Sq-NSCLC with enhanced FGFR1-4 and MET gene expression – NGS pilot study.
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


Characteristics and prognostic relevance of p53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Overall survival analysis and characterization of an EGFR mutated non small cell lung cancer (NSCLC) population
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011



Epithelial growth factor receptor (EGFR) mutation status and the treatment of non-small cell lung cancer (NSCLC): A population based quality assurance analysis
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015


Differential expression analysis of lncRNA in different types of lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021


Tumor stage and survival critical comparison of survival data obtained from a field study with those from the literature
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002

Quantitative RT-PCR 3-gene expression signature predicts survival in early-stage non-small cell lung cancer (NSCLC) patients (pts)
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Survival prognosis and target therapy best response in adenocarcinoma lung cancer pts with mutation EGFR gene
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

(Array)CGH analysis of chromosomal gains and losses in human malignant pleural mesothelioma cell lines: Involved loci and genes
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010

The methylation profiling of multiple tumor suppressor genes in plasma cell-free DNA from patients with NSCLC versus non-malignant tumors - pilot study
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

In silico gene expression analysis of small cell lung cancer
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010


Gene expression patterns in lung emphysema. A gene microarray analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 87s
Year: 2002

Where next for lung cancer gene expression profiling?
Source: Eur Respir J 2007; 30: 5-6
Year: 2007


The role of EGFR expression in the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001

LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016

FGFR1-4 and MET expression analysis and evaluation of reliable reference genes in Sq-NSCLC
Source: International Congress 2019 – Biology of lung cancer
Year: 2019